High-risk human papillomavirus cervical infection prevalence: a nationwide retrospective study comparing opportunistic and organised screening, France, 2020 to 2023.

Saved in:
Bibliographic Details
Title: High-risk human papillomavirus cervical infection prevalence: a nationwide retrospective study comparing opportunistic and organised screening, France, 2020 to 2023.
Authors: Supplisson O; Sorbonne University, Paris, France.; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France., Tessandier N; ExposUM Institute, Université de Montpellier, MIVEGEC, Montpellier, France.; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France., Roussel M; Laboratoire Cerba, pole infectiologie, Frépillon, France., Haim-Boukobza S; Cerba HealthCare, Issy-les-Moulineaux, France., Burrel S; CNRS UMR 5234, Fundamental Microbiology and Pathogenicity, Université de Bordeaux, Bordeaux, France.; CHU de Bordeaux, Service de virologie, Bordeaux, France., Sofonea MT; Department of Anesthesiology, Critical Care, Intensive Care, Pain and Emergency Medicine, CHU Nîmes, Nîmes, France.; PCCEI, Université de Montpellier, INSERM, Montpellier, France., Alizon S; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France.
Source: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2025 Jul; Vol. 30 (28).
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1560-7917
DOI:10.2807/1560-7917.ES.2025.30.28.2400689